PAR:ALBPS
Biophytis S.A. · PAR · Healthcare · EUR · FY for 2024
Figures on this page computed 2026-11-07 18:27 UTC
Last close
n/aEUR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2024
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Safety is the furthest below its sector's middle: 0.03 against 0.72 on the market's range.
- Growth39.0%71 of 100, above its sector
- Returns on capital-150.4%4 of 100, below its sector
- Marginsn/anot placed
- Pricen/anot placed
- Safety0.253 of 100, below its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- Price: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
3 of 5 readExcept where said otherwise: Computed from the filing for 2024
- Salesn/a
Its own average over 0 years.
- Profit0.63x
Its own average over 10 years, -16.6M.
- Free cash flow0.71x
Its own average over 10 years, -12.2M.
- Debt1.15x
Its own average over 10 years, 8.6M.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 0.63 times.
The filed years, as a table
10Each line is 100 at 2015-12-31, the first year we hold.
| Filed year | Shares in issue |
|---|---|
| 2015-12-31 | 100.0 |
| 2016-12-31 | 127.5 |
| 2017-12-31 | 188.8 |
| 2018-12-31 | 274.9 |
| 2019-12-31 | 347.0 |
| 2020-12-31 | 1,232.5 |
| 2021-12-31 | 2,430.8 |
| 2022-12-31 | 3,593.1 |
| 2023-12-31 | 11,160.6 |
| 2024-12-31 | 42,680.4 |
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- EUR
Figures behind the shape
Growth
39.0%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
One-year change in net income39.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Returns on capital
-150.4%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
Return on equityn/mnegative equity
Negative equity.
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
Return on assets-150.4%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
Margins
n/aWe do not hold this figure for this company, so there is nothing to place.
wider is higher, with no cohort held
Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
Operating marginn/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
Net marginn/a
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
Free cash flow marginn/a
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
Price
n/aWe do not hold this figure for this company, so there is nothing to place.
cheaper is higher, with no cohort held
Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2024
Price to bookn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2024
- computed
- Computed from the filing for 2024
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
Price to sales ration/a
We do not hold this figure for this company, so there is nothing to place.
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2024
- Computed from the filing for 2024
Safety
0.25safer is higher, placed against 4,231 companies as of 2026-11-06
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
Current ratio0.25
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.